Headed to ACS San Diego? Join us for Happy Hour!
← Back to glossary

Molecular Dynamics (MD) Simulations

Field
Field
Field

Molecular Dynamics (MD) simulations is a computational technique used to study the physical movements of atoms over time. By solving Newton's equations of motion, MD simulations provide detailed information about the trajectories of atoms in a system, allowing researchers to observe the dynamic behavior of biological molecules in a simulated environment. A major consideration is the simulation time used to sample different states. Sometimes, large energetic barriers exist that cannot be overcome by longer simulations. Enhanced MD can be a solution.

Importance in Computational Drug Discovery

  1. Conformational Analysis: MD simulations help in understanding the different conformations that a target or ligand can adopt, which is crucial for drug design.
  2. Binding Mechanisms: They can provide insights into where a ligand binds, how a ligand enters or exits the binding site, and how long the ligand stays in place.
  3. Stability and Dynamics: MD simulations allow the assessment of the stability and flexibility of target-ligand complexes, which are important for predicting biological activity.
  4. Free Energy Calculations: They facilitate the calculation of free energy changes associated with binding, which helps in ranking the binding affinities of different ligands.
  5. Allosteric Sites Identification: MD simulations can reveal non-canonical binding sites that module endogenous function, called allosteric sites.

Key Tools

  1. GROMACS: A versatile package for performing MD simulations, particularly known for its efficiency and scalability.
  2. AMBER: A suite of programs for MD simulations of biomolecules, widely used in academia and industry.
  3. NAMD: A parallel, object-oriented molecular dynamics code designed for high-performance simulation of large biomolecular systems.
  4. CHARMM: A program for macromolecular simulations, including MD, Monte Carlo, and free energy calculations.

Literature

"Applications of Molecular Dynamics Simulations in Drug Discovery"

DOI: 10.1007/978-1-0716-3441-7_7

Summary: Provides an overview of the current applications of MD simulations in drug discovery, including detecting protein druggable sites, validating drug docking outcomes, and exploring protein conformations.

"Molecular Dynamics (MD) Simulations Provide Insights into the Activation Mechanisms of 5-HT2A Receptors"

Publication Date: 2024-10-01

DOI: 10.3390/molecules29204935

Summary: Characterizes protein dynamics of the 5HT2A receptor stimulated by ligands using 1 µs MD simulations, providing insights into receptor activation mechanisms.

"Molecular Dynamics Simulations in Drug Discovery and Pharmaceutical Development"

Publication Date: 2020-12-30

DOI: 10.3390/pr9010071Summary: Reviews the current application possibilities of MD in drug discovery and pharmaceutical development, including target validation, lead discovery, and pharmaceutical formulation development.

"From Byte to Bench to Bedside: Molecular Dynamics Simulations and Drug Discovery"

Publication Date: 2023-12-29

DOI: 10.1186/s12915-023-01791-z

Summary: Discusses how MD simulations have advanced to become powerful tools for investigating dynamic interactions between potential small-molecule drugs and their target proteins.

"Role of Molecular Dynamics and Related Methods in Drug Discovery"

Publication Date: 2016-02-08

DOI: 10.1021/acs.jmedchem.5b01684

Summary: Reviews the theoretical background of MD and enhanced sampling methods, focusing on free-energy perturbation, metadynamics, steered MD, and other methods used to study drug-target binding.

"Discovery of a Heparan Sulfate Binding Domain in Monkeypox Virus H3 as an Anti-Poxviral Drug Target Combining AI and MD Simulations"

Publication Date: 2024-11-27

DOI: 10.7554/eLife.100545

Summary: Combines AI-based structural prediction tools and MD simulations to identify a novel domain in MPXV H3 protein, leading to the design of a protein inhibitor that disrupts viral adhesion.

"Molecular Dynamics Simulations in Drug Discovery and Drug Delivery"

DOI: 10.1007/978-3-030-36260-7_10

Summary: Discusses the role of MD simulations at different stages of the drug discovery process and how they aid in understanding molecular systems.

"Molecular Docking, ADMET Analysis and Molecular Dynamics (MD) Simulation to Identify Synthetic Isoquinolines as Potential Inhibitors of SARS-CoV-2 MPRO"

Publication Date: 2023-01-23

DOI: 10.2174/1573409919666230123150013

Summary: Integrates molecular docking, ADMET analysis, and MD simulations to identify isoquinoline derivatives as potential inhibitors of SARS-CoV-2 MPRO.

"Discovery and Validation of the Binding Poses of Allosteric Fragment Hits to Protein Tyrosine Phosphatase 1b: From Molecular Dynamics Simulations to X-ray Crystallography"

Publication Date: 2023-04-22

DOI: 10.1021/acs.jcim.3c00236

Summary: Uses long-timescale MD simulations to discover binding poses for fragments in allosteric pockets on PTP1b, validated by X-ray crystallography.

"Recent Insights from Molecular Dynamics Simulations for GPCR Drug Discovery"

Publication Date: 2019-08-29

DOI: 10.3390/ijms20174237

Summary: Highlights recent MD simulation studies and enhanced sampling methods used to study biased GPCR signaling and their conformational dynamics.